These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36892023)

  • 21. Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility.
    Petrik J; Verbanac D; Fabijanec M; Hulina-Tomašković A; Čeri A; Somborac-Bačura A; Petlevski R; Grdić Rajković M; Rumora L; Krušlin B; Štefanović M; Ljubičić N; Baršić N; Hanžek A; Bočkor L; Ćelap I; Demirović A; Barišić K
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review.
    Song D; Wang F; Ju Y; He Q; Sun T; Deng W; Ding R; Zhang C; Xu Q; Qi C; Bao J
    Int J Surg; 2023 Apr; 109(4):925-935. PubMed ID: 36974713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
    Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
    J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Noncoding RNAs Have a Promising Future Acting as Novel Biomarkers for Colorectal Cancer.
    Wang JJ; Wang X; Song YX; Zhao JH; Sun JX; Shi JX; Wu ZH; Wang ZN
    Dis Markers; 2019; 2019():2587109. PubMed ID: 31275444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
    Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
    Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Value of Circulating Tumor Cells in Prognosis of Stage III/IV Colorectal Cancer After Oxaliplatin-based First-line Chemotherapy.
    Yu J; Zhang J; Peng T; Fei Z; Jin L; Yang M
    In Vivo; 2022; 36(2):806-813. PubMed ID: 35241536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
    Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction.
    Nassar FJ; Msheik ZS; Nasr RR; Temraz SN
    Clin Epigenetics; 2021 May; 13(1):111. PubMed ID: 34001239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of liquid biopsy and immunotherapy: opening a new era in colorectal cancer treatment.
    Yao S; Han Y; Yang M; Jin K; Lan H
    Front Immunol; 2023; 14():1292861. PubMed ID: 38077354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.
    Wang M; Zhang Z; Pan D; Xin Z; Bu F; Zhang Y; Tian Q; Feng X
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular biomarkers in the diagnostic of patients with colorectal cancer.
    Fabišíková K; Behulová RL; Repiska V
    Neuro Endocrinol Lett; 2019 Dec; 40(5):215-221. PubMed ID: 32112545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer.
    Abdalla TSA; Meiners J; Riethdorf S; König A; Melling N; Gorges T; Karstens KF; Izbicki JR; Pantel K; Reeh M
    PLoS One; 2021; 16(6):e0252897. PubMed ID: 34111181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Circulating Tumor Cells in Colorectal Cancer as an Adjunctive Non-invasive Diagnostic Method.
    Nursyirwan SA; Abdullah M; Sulaiman AS; Rinaldi I; Makmun D; Simadibrata M; Noor DR; Wiraatmadja A; Jeo WS; Rahadiani N; Handjari DR; Shatri H
    Acta Med Indones; 2023 Oct; 55(4):385-395. PubMed ID: 38213054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of circulating tumor cells and DNA in the management of advanced colorectal cancer.
    Pan X; Zhang X
    Future Oncol; 2020 Jun; 16(18):1289-1299. PubMed ID: 32379501
    [No Abstract]   [Full Text] [Related]  

  • 38. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential of liquid biopsy in the management of cancer patients.
    Markou A; Tzanikou E; Lianidou E
    Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.